RapidAI
Latest round
- Series C
Last raised
- Jul 2023
Total raised
- $75M
Investors
- 1
About RapidAI
Founded in 2012 and based in Colorado, iSchemaView, Inc.iSchemaView, Inc. specializes in developing AI-driven solutions for clinical decision-making, particularly in neurovascular conditions.00 mn from Vista Equity Partners. The company has not reported any pivots or changes in business strategy since its inception.RapidAI is a clinical AI platform specializing in decision support tools tailored for various disease states, particularly in neurovascular care. Its core offerings include rapid assessment solutions for ischemic strokes, hemorrhagic events, and aneurysms, which enhance clinical decision-making through real-time data analysis and AI-driven insights. The platform facilitates imaging prioritization and alerts for urgent cases, enabling clinicians to identify suspected anomalies and automate key metrics such as blood flow and anomaly growth. RapidAI's products are designed to integrate seamlessly into existing healthcare systems, ensuring interoperability across the healthcare ecosystem.RapidAI's revenue model primarily revolves around subscription-based partnerships with healthcare institutions that utilize its AI-driven clinical solutions. Clients engage with the platform on a recurring basis, which allows for continuous access to advanced analytics, clinical decision support, and ongoing updates. The company's flagship offerings include proprietary tools for rapid detection and assessment of stroke and aneurysm-related conditions, which are pivotal in emergency medical settings. The company plans to introduce new products designed to enhance its offering in neurovascular care and is targeting expansion into new geographic regions, including Europe and Asia, by the end of 2024. This strategic growth plan is aimed at increasing the accessibility and applicability of its AI-driven solutions in diverse healthcare environments.
Who invested in RapidAI
1 investor across 1 round
See all investors in RapidAI
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Jul 20, 2023
Amount
$75M
Investors
Questions about RapidAI
Who invested in RapidAI?
RapidAI has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has RapidAI raised?
RapidAI has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did RapidAI last raise money?
RapidAI's most recent round on record is a Series C, in Jul 2023.
What does RapidAI do?
Founded in 2012 and based in Colorado, iSchemaView, Inc.
Where is RapidAI headquartered?
RapidAI is headquartered in Menlo Park, US.
Which VCs invest in companies like RapidAI?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at RapidAI's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like RapidAI? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.